...
首页> 外文期刊>Chemweek's business daily >Ampac Fine Chemicals Signs API Manufacturing Deal
【24h】

Ampac Fine Chemicals Signs API Manufacturing Deal

机译:Ampac Fine Chemicals签署API制造协议

获取原文
获取原文并翻译 | 示例
           

摘要

Ampac Fine Chemicals (AFC; Rancho Cordova, CA), a subsidiary of American Pacific (Las Vegas, NV), says it has signed an agreement with Chimerix (Durham, NC), to validate at commercial scale the manufacturing process for the active pharmaceutical ingredient (API) in Chimerix’s antiviral drug candidate, CMX001, which is being developed for the prevention and treatment of smallpox.
机译:美国太平洋公司(内华达州拉斯维加斯)的子公司Ampac Fine Chemicals(AFC; Rancho Cordova,CA)表示已与Chimerix(北卡罗来纳州达勒姆)签署了一项协议,以商业规模验证该活性药物的生产工艺Chimerix的抗病毒药物候选药物CMX001中的成分(API),该药物正在开发中用于预防和治疗天花。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号